| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.005 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |